After AVP bankruptcy – every fifth pharmacy in bankruptcy shock

Drama in the healthcare sector: one in five pharmacies is in dire straits. The bankruptcy of the Düsseldorf accounting center AvP is to blame. Around 3,500 of the 19,000 pharmacies in Germany are customers of the company. This week it filed for bankruptcy and owes the pharmacists a three-digit million sum.

“For me and my colleagues, the situation is existentially threatening,” says Monika Herzog (59). The pharmacist from Wiesloch (Baden-Württemberg) is a customer of AvP. “Very few of us have the financial reserves to make the payments due to wholesalers.” The claims would bring them to the subsistence level. They needed short term loans. “I myself have 260,000 euros outstanding,” says Monika Herzog.

Service providers such as AvP help pharmacies with the billing of prescriptions: The pharmacies buy their medication wholesalers, give them to patients against a prescription and forward the prescriptions to companies such as AvP. They submit the prescriptions to the health insurers, receive the money and forward it to the pharmacies, which in turn use them to buy medicines. “The wholesale bills must be paid by the 15th of the month,” says Monika Herzog. But on this 15th AvP filed for bankruptcy.

Bankruptcy cannot only ruin many pharmacists. It also jeopardizes the supply of medicines. “I hope wholesalers are still interested in us,” says Monika Herzog. “He makes advance payments with the pharmacies. But if there is no money, he will not deliver any goods. And it is already being announced that the September funds will look the same as in August. ”

Photo: Jan Woitas / dpa

“data-zoom-src =” 72995454 / Bild / 6.bild.jpg “/>

The drug stores in pharmacies are automated – but if the flow of money stalls, they remain emptyPhoto: Jan Woitas / dpa

“There are also criminal investigations going on here,” adds Arndt Kempgens. “Because in situations like this there is always the risk that something could have been withheld. Sometimes the public prosecutor’s office still finds money that has seeped into some channels – with the result that something can still be distributed to customers. In normal insolvency proceedings, in our experience, this is only around two percent of the insolvency sum, i.e. only a minimal part. “

“We pharmacists play such an important role in the healthcare sector,” says Monika Herzog. “We need a rescue package from politics!” In addition, she calls for better controls in the medium term and state supervision of the accounting system – as with the Association of Statutory Health Insurance Physicians.

Arndt Kempgens remains skeptical: “I cannot imagine a state rescue package. Every company and every pharmacist will have to individually see how they are dealing with this huge financial problem. That will be the challenge for the next few months. “

What did you experience? Write to


Michel Cymes tells you everything you need to know about doctor’s prescriptions

Every day in France, some 4 million people cross the threshold of a pharmacy, most of them with a prescription in hand. But sometimes the document is a little complicated to decipher, literally as well as figuratively. Yes handwritten prescriptions are increasingly rare, they often require a lot of patience to understand them.

Several information must imperatively appear on the prescriptions. In this case, this is the name and affiliation number of the doctor, patient’s first and last name, the weight of the patient, especially if it is a child because this can have consequences on the dosage, the doctor’s signature and finally, the date of the prescription, because they are generally valid for three months.

Some prescriptions may be valid up to 1 year as is the case with certain treatments for chronic diseases in the image of diabetes. However, the very first time you go to the pharmacist, your prescription is less than 3 months old. In addition, do not expect to stock up on drugs for more than a month, even if you have a long-term prescription. You will have to return to the pharmacy every month.

Some exceptions to know

Rare exceptions nevertheless depart from this rule of returning to the pharmacy every month. When the drug exists in quarterly packaging, in other words, the box contains everything you need for three months of treatment. The other exception is when you go abroad for more than a month. You must have reported this to your doctor and he must have done the same with social Security so that she gives her consent.

Pharmacists are prohibited by law from giving you medication if you do not have your prescription. The rare cases that are an exception to this rule are when you have chronic disease and that you are on treatment. The pharmacist can then help you outone box of drugs, as small as possible, if he considers that the treatment is essential for you and that its suspension could be harmful to your health.

Other case where a prescription is not necessarily necessary, for women, it is the pill. The pharmacist can help you out, but only if you are able to present a prescription for less than a year.

The editorial staff recommends you

Read more


Teva accused of cartel on drug prices in the United States

Israeli generic drug giant Teva is being sued by U.S. authorities for an illegal drug price cartel between 2013 and 2015, according to a U.S. Department of Justice statement released on Tuesday, charges the group denied.

Authorities accuse Teva and its co-conspirators of agreeing to fix prices, rig tenders and distribute customers for several generic drugs, including the popular cholesterol-lowering Pravastatin.

In total, the patients would have paid 350 million dollars more than they should have, assures the Department of Justice.

“Teva is deeply disappointed that the government has chosen to continue these prosecutions,” the group responded in a statement. He claims to have conducted an internal review over four years and, on this basis, he “firmly rejects the allegations and will vigorously defend the company in court.”

The group says it has cooperated with investigators and tried to find an amicable solution. But according to him, the Justice Department “refused to consider alternatives that would not have a profound impact on Teva and the parties that depend on the group, including the patients who benefit from our drugs.”

Teva claims that one in ten generic drug prescriptions in the United States are for its products.

Five companies prosecuted in this case have already paid heavy fines to settle the lawsuits.

Sandoz, a subsidiary of Swiss pharmaceutical giant Novartis, had thus agreed to pay a fine of 195 million dollars in March and the American subsidiary of the Israeli group Taro Pharmaceuticals, 205.7 million dollars in July.

Other companies involved include Apotex, which agreed to pay a $ 24.1 million fine in May, and Glenmark, who was indicted by a grand jury in July.

Teva, which sold $ 17 billion worth of drugs last year, was also accused earlier this month by US officials of artificially inflating the price of reimbursements for its multiple sclerosis drug Copaxone for government-run Medicare patients.


The 300 hi-tech startups born in 2020: “This is how we challenge the Covid crisis”

The secret of agriculture? It reveals itself with satellites. Cosmetics? A bargain from pharmacies. It is up to innovative startups to look far and create new businesses that unite sectors (apparently) far from each other. In Milan there are over 2,300 futuristic companies, 70 per cent of those in Lombardy, a fifth of the Italian total. These are mainly companies that offer services (1,954 in the city). A smaller share concerns industry or crafts (255 startups). But even those who engage in agriculture or fishing can boast of the innovation stamp, as long as they meet the criteria required by the appropriate register, such as the predetermined quota of investments in development or the presence of researchers in the team. Not even the coronavirus epidemic and the subsequent lockdown have stopped the wave of the businesses of tomorrow: the Chamber of Commerce has 300 start-ups in the Milanese area in the first seven months of 2020, while from January to August there are more than 7,600 companies registered in the city, of which a third in the center.

Who are the innovative entrepreneurs? Behind the numbers and percentages there are stories, ideas and projects developed to meet new needs. the case of Inpharma Service, a company that deals with providing services to pharmacies – explains the scientific manager Norberto Festo -. Many have started selling cosmetics and services to offset the loss of drug-related revenue. A few years ago also the aesthetic booths were born inside them. But pharmacists often don’t have a commercial bent. The startup intervenes to help them. We provide “turnkey” beauty services. With the pharmacist we take care of tracing and bringing customers to the pharmacy, where they meet beauticians and beauty expert prepared and constantly updated. Open just before the Covid-19 emergency, now the young company is ready to make up for lost time. In Italy there are about 19 thousand pharmacies – reasons Festo -. Of these, 10/15 percent already have an aesthetic cabin. In the majority of cases they are centers in Northern Italy. Inpharma already brings its offer to Emilia, Lombardy, Veneto but also to Umbria and Marche. It intends to expand in Italy and Europe. I believe that at this moment we need to make “order” in the cosmetics sector. People seek security, which is why companies need to work more professionally. And we can do our part.

Wapi’s founders bet on agriculture instead, app dedicated to precision agriculture. The company includes Vincenzo Morelli, Lorenzo Piovani, Luigi Mazzer, Paolo Ripamonti and Camilla Comaschi, all aged between 24 and 27 years. Elia Colombo, Paola Alois and Elisa Bulgaro collaborate with them in the development of the app. The goal is to support the farmer with the technology for irrigation and fertilization choices – explains Morelli -. Instead of just relying on your own experience. will be able to analyze the needs of the field thanks to the images captured by the satellites. And thus understand where and how much to water, for example. The advantages? Savings of costs, time and less environmental impact. The idea was born within the Alta Scuola Politenica. Now the startup, officially born on July 1st, is following an acceleration program. In a month, he will launch the first version of the app, which allows you to digitize the campaign notebook.

The target of Mr. Pos is different, which with Wapi shares the registration date in the business register. The portal helps merchants to choose between the offers of operators for pos services for electronic payments explains Leonardo Stenico, 28, partner of Marco Sittoni (56) and Riccardo Di Camillo (51). It allows for a simple comparison. With each new contract, the operator recognizes us one fee. The health emergency could favor the growth of the portal: In this phase it is preferred to pay contactless, the shops have to adapt. Innovative enterprises teaching: the future is already here.

16 August 2020 | 08:30



2020-2021 will be a record influenza vaccination season

Global flu vaccine makers have produced a record number of doses for the 2020-2021 season, as authorities hope to relieve hospitals sick with flu as a rebound in the Covid-19 pandemic is expected.

For the 330 million Americans alone, a total of 194 to 198 million doses of vaccine will be produced this season, up from 175 million last year, an 11% increase, according to the Centers for Prevention and Control. diseases (CDC).

The giant network of pharmacies CVS, where vaccination is done without a prescription, has ordered double the doses compared to 2019, or 18 million.

The manufacturer Seqirus expects 15% additional production (60 million doses against 52), as Sanofi (80 million against 70). Globally, the French group recorded an increase of 20%.

“We have received tremendous demand from our customers,” Michael Greenberg, North America medical officer for vaccines at Sanofi Pasteur, which is one of the big three manufacturers along with Seqirus and GSK, told AFP.

Sanofi shipped its first batches on July 22, three weeks earlier than in 2019.

– “Very worried” –

The flu killed between 24,000 and 62,000 people in the United States last year. By helping to free up hospital beds, influenza vaccination is seen as one of the public health measures to cushion the other epidemic, that of Covid-19.

“I am very worried about the fall,” Lawrence Gostin of Georgetown University told AFP, calling in the medical journal Jama for a very offensive vaccination campaign, or even compulsory vaccination in schools. “People don’t think of the flu, they only think of Covid”.

Americans are already among the most vaccinated against influenza in the world: vaccination is recommended from the age of six months, when other countries, including France, recommend it to people at risk of complications, including those over 65 years.

As a result, 63% of children and 45% of American adults were vaccinated in 2018-2019 – and 68% of over 65s, against half in France.

But this year, Americans are going to have to change their ways. “A lot of people are normally vaccinated at work or on campus, but a lot of businesses or schools are closed,” warns Lawrence Gostin.

– Happy flu year? –

The industry is running in: in February and March, the World Health Organization and national health authorities select the four strains of influenza virus most likely to be in circulation the following winter in the northern hemisphere.

Hundreds of millions of eggs – the traditional medium for incubating viruses before inactivating them and making them into vaccines – are delivered to laboratories, then production continues throughout the spring, until the syringes are filled. ‘summer.

For Sanofi in the United States, everything happens in two factories in Pennsylvania and in New York State. The same who could produce a future vaccine against the new coronavirus.

But for now, there is no competition, says Michael Greenberg, and the US government has given the group $ 2 billion anyway to expand its production lines.

“We have everything we need and we are working closely with our vial and syringe suppliers for the next few years,” said Dave Ross, Director of Commercial Operations for Seqirus in North America, regarding glass and others. distribution materials that will be essential for future anti-Covid vaccines.

An optimistic scenario is also possible for the winter: barrier gestures and wearing a mask should reduce the incidence of all respiratory viruses, including those of the flu.

“We hope this all pays dividends, and that there will be less flu,” says Henry Bernstein of the Hostra / Northwell School of Medicine, also a member of the Advisory Council on Immunization Practices.


Dr. Alejandro Junger: The first pharmacy is our kitchen

“When I grew up in Uruguay 50 years ago there were no supermarkets. My mother cooked all day and with my father once a week we went to the farms. As a child I learned to distinguish which farmer raised his vegetables with love and which one did not. It was another life, with fewer comforts, but much healthier because we ate real foods, “recalled the Dr. Alejandro Young in the DIARIO LAS AMÉRICAS digital program, Café con Camila.

Graduated from the Faculty of Medicine in Uruguay, the renowned doctor moved to New York to carry out his postgraduate degree in Cardiology. It was there that his research journey began and the journey that shaped him as a physician.

“During the 6 years that my specialization lasted in New York, the life change was so drastic that I started to get sick. I started to gain weight, developed allergies, my digestion was not working well, and I suffered from bloating, constipation and diarrhea. But what scared me the most is that I didn’t want to live. “

“I consulted with my colleagues, and I ended up with three diagnoses: severe allergy, severe depression, and irritable bowel. I remember being given 7 prescription drugs to kill the symptoms, but I was never convinced of my diagnosis and started looking for other solutions. And in that search I found many of the things that are the basis of my life and my professional practice ”, he said.

A new way of life

When the Dr. Alejandro Young After finishing his specialization in Cardiology, he decided to go to a monastery in India to learn how to meditate. There he was exposed to Chinese, Ayurvedic, naturopathic, osteopathic medicine, among others.

“I worked as a doctor there, and it opened my eyes and the possibilities. I was impressed with how strongly these other forms of medicine think and decide what to do with a patient. We arrogantly call these practices alternative medicine, but they have been practiced for more than 5 thousand years in the world, modern medicine and drugs are really the alternative ”.

After that experience, the Dr. Younger He returned to the United States to rejoin the formal health system.

“I was very frustrated. It is a business and justifying my salary meant that I had to see 1 patient every 7 minutes. She couldn’t work that way. Chronic diseases are not well understood or treated by the medicine modern ”, he sentenced.

What a person eats, how they think, who they meet, their level of satisfaction in life, all of this should be conceived as part of a patient’s diagnosis, says the Dr. YoungerTherefore, through his books, he invites us to conceive health taking into account the person and their environment.

“Most of the chronic diseases that people suffer are caused by some microorganism, toxins or by a combination of both. And of course, due to the lack of the necessary nutrients that are responsible for detoxifying the body and defending it from microorganisms ”.

“To feel better we have to eliminate 5 basic groups: alcohol, coffee, dairy products, gluten and sugar. When someone succeeds immediately, their body begins to function better. You have to eat real foods, as designed and as provided by nature. The problem is that 90% of the things we find in supermarkets have preservatives, sweeteners, colorants, flavorings, solvents, etc., all of this destroys our health ”.

Finally, the cardiologist recommended that they strengthen the immune system by consuming the complete range of foods that nature provides us.

“Vitamin C, Zinc, melatonin, vitamin D, pre and probiotics help a lot. Now that we are in a pandemic time, garlic and onion are antiviral and antibacterial, so it is worth consuming them, like ginger ”, he concluded.


US approval of Evrysdi for spinal muscular atrophy

The Swiss pharmaceutical group Roche has obtained approval in the United States of Evrysdi, a new treatment for spinal muscular atrophy, he announced on Monday.

The US drug agency, the Food and Drug Administration (FDA), has given the green light to this drug for children aged two months and older as well as for adult patients affected by this severe neurodegenerative disease, has it stated in a statement.

Also called risdiplam, this drug is “the first and only” treatment that can be given at home, Roche said. In liquid form, it can be administered directly orally or through a food probe.

The approval was granted based on the results of two studies involving 450 patients at different ages and stages of the disease, which demonstrated significant improvement in important motor functions.

Spinal muscular atrophy is a rare but serious neurodegenerative disease linked to a defective gene that causes muscle atrophy. Babies affected by this disease quickly lose motor neurons for essential muscle functions, such as breathing, swallowing, speaking, and walking.

Without treatment, the baby’s muscles weaken and gradually progress to paralysis or death. The disease affects about one in 10,000 babies, Roche said. The treatment will be available in the United States within two weeks, said the Swiss laboratory.

Long considered incurable, the treatment of this disease has made significant progress with the arrival on the market of new classes of drugs, promising but very expensive. At the end of 2016, the American Medicines Agency first approved the treatment from the American laboratory Biogen, called spinraza, then gave the green light last year to gene therapy from its Swiss competitor Novartis, called Zolgensma.

“Although it is arriving late on the market,” Roche’s treatment should find its place among its competitors, especially thanks to its oral formula, said Stefan Schneider, analyst at Vontobel, in a stock market commentary. For the moment, he estimates the potential annual turnover of this drug, at its peak in sales, at around 500 million Swiss francs (463 million euros).

Despite this approval, the title yielded 0.08% to 313.95 Swiss francs at 10:30 GMT, against the trend of the SMI, the flagship index of the Swiss Stock Exchange, up 0.51%, weighed down by a setback during clinical trials on another treatment.

In a separate statement, Roche said “mixed” results for its investigational drug etrolizumab in clinical trials for bowel disease.


the beginning of requisitions against laboratoires Servier and MSNA

After months of hearing, interrupted because of the outbreak of Covid-19, the charge starts to take on Tuesday morning, June 23, its claims against laboratoires Servier and the Agency of the drug, tried in Paris in the case of the scandal health Mediator. The indictment of lawyers, Aude Le Guilcher and Cristina Mauro, expected to last a day and a half, must start at 10 hours.

→ TO READ. Mediator : the last debates in the trial interrupted by the pandemic of sars coronavirus

Laboratoires Servier – home-mother, and nine companies of the group – and the national security Agency of the drug (MSNA, former Afssaps) are liable for heavy fines and compensation to many victims. Jean-Philippe Seta, the former number 2 of the group and the main accused among the persons physical, risk, to the difference of persons, a prison sentence. Several former managers and experts of health authorities are also continued to be suspected of conflict of interest with the laboratories Servier.

The trial of the Mediator, one of the worst scandals French health, was opened last September 23 in front of the correctional court, nearly ten years after the market withdrawal of the drug responsible for hundreds of deaths. Because of Covid-19, the debates were interrupted between 16 march and 8 June.

Placed on the market in 1976 as an adjuvant in the treatment of diabetes, but widely diverted as appetite suppressant, it is prescribed to approximately five million people during the 33 years of its marketing. The question of the longevity, while the early warnings about its danger have been issued since 1995, has led six months of discussions, often technical and dry.

“Evidence “

The pharmaceutical firm and the former number 2 of Jacques Servier – the all-powerful president and founder of the laboratories, who died in 2014 – are accused of having knowingly concealed the properties anorectic Mediator and its toxicity. They are tirelessly defended, pointing to” errors of appreciation “but refuting any intentional fault. They are pursued in particular for” aggravated tort of deceit “, “ scam “and” homicide and unintentional injury “.

→ TO READ. “I had to bang one’s fist on the table to get my order of Mediator “

This last offence is also alleged against the Agency of the drug, considered to to mistakes not intentional, for being late to suspend the marketing of the drug. Its current director-general assumed at the hearing” part of the responsibility “in the drama of health and will not be seeking the release.

Trial of the Mediator : the beginning of requisitions against laboratoires Servier and MSNA

More than 6,500 people are civil parties in total, of which at least 4 600 victims in “direct” and a hundred of sickness insurance funds, which have supported the repayment of the Mediator. In total, approximately one billion euros in compensation have been claimed, indicated the lawyers of the civil parties.

Sick, away, “ cynical “or “ impoverished “many victims did not attend the trial. Their lawyers have denounced in their names” the attitude of denial “laboratories Servier despite “ obviously “that “ ever the Mediator would not have had to be marketed “, has insisted Jean-Christophe Coubris, which represents 2 600 civil parties. The defence will take the floor beginning Monday, June 29. The end of the trial scheduled on 6 July. Decision in 2021.


Why does California have low COVID-19 numbers in the US drama? – Telemundo 52

LOS ANGELES – Early confinement and other prevention measures promoted by the state government have allowed California, with more than 40 million inhabitants and some 300 deaths from COVID-19, to become an example of how to deal with the coronavirus pandemic in United States.

So far, the nation’s largest metropolis, Los Angeles, with more than 10 million citizens, has recorded fewer than 6,000 cases and 132 deaths, far from New York City, which has 8 and a half million inhabitants. and it has confirmed some 130,000 infections and more than 4,000 deaths.

“California has been doing quite well in the COVID-19 pandemic, with a relatively low number of infected per 100,000 people and a low death rate,” said Professor Karin Michels, head of the Department of Epidemiology at the School of Public Health, University of California Los Angeles (UCLA).


California Governor Gavin Newsom was one of the first in the country to enact relatively strict confinement, allowing only “essential” activities such as going to the grocery store and pharmacy, and exercising respect for safety distances between people.

In contrast, eight states – Arkansas, Iowa, Nebraska, North Dakota, South Dakota, South Carolina, Utah, and Wyoming – have not mandated their residents to stay home.

“The governor issued ‘home security’ and ‘shelter’ orders relatively quickly. Universities like UCLA and other large employers closed even earlier and sent people to work, teach and study from home,” said Michels, who has extensive experience in disease prevention, public health and statistical methods.

Due to the COVID-19 crisis, California schools may continue to be closed until the end of August.

Newsom also took the initiative to decree the closure of schools, which will remain closed until next year, as a preventive measure; in asking President Donald Trump to send a hospital ship to Los Angeles to support local hospitals before it reached a hypothetical peak in the number of cases, which has not yet occurred; and in closing the state’s beaches and parks.

Another point that seems to have helped so far in the exceptional case of California against COVID-19, according to experts, is the low population density of the state, which reduces the possibility of contagion and allows better compliance with the rules of social distancing.

 Despite having a large population, Californians do not live in
as dense as New Yorkers. Cities spread with
Few skyscrapers: Relative to other states, many more people in
 California lives in houses, not in apartment buildings or buildings
high, “summarizes Michels, who is based on data from a study of his


California has had a much lower per capita death rate than most of the nation’s largest states, with the exception of Texas.

“The state has a low average age and a high
density of healthcare facilities, which may have contributed to
 the low mortality rate, “explained Michels.

According to a recent study published in The Lancet, the mortality rate among those infected with 20 years of age is 0.03%, while for those 70 years of age it is 8.6%.

Cautious tone

 Californian authorities have projected alarming numbers in the
recent weeks, although so far those estimates have not been

Newsom himself foresaw two weeks ago that more than half the state’s population, or about 25 million people, would become infected, so he begged its residents to follow the guidelines to the letter.

For his part, the mayor of Los Angeles, Eric Garcetti, did not hesitate to forecast that the city “would follow in the footsteps of New York” in number of cases, a catastrophic scenario that is still far away.

COVID-19 affects children differently than adults. This is what the doctors say in the following video.

The United States on Monday exceeded 10,000 deaths from coronavirus, with 10,335 and almost 350,000 infected, making it the third country with the most deaths after Italy and Spain, according to the count of the Center for Systems, Science and Engineering (CSSE) from Johns Hopkins University (Maryland).

The new data is known after this Sunday
President Donald Trump, during his usual daily press conference,
make sure “this will probably be the hardest week, between this
week and next, and there will be a lot of death. ”

The state of New York, the great epicenter of the pandemic in the United States, accumulates with these latest figures a total of 4,758 deaths and 130,689 confirmed cases of COVID-19, compared to just over 122,000 that it had a day earlier.


Coronavirus: Arcuri, on masks sentences by liberal setters – Politics

“I would have a great desire to speak from the trench in which I have been with Dr. Borrelli and our collaborators for 40 days, to talk about the liberals who issue daily sentences from a sofa with a cocktail in hand. But I won’t do it, my duty is to work “. The commissioner said so Domenico Arcuri in a press conference at the Civil Defense, arguing with those who “say that the price of the masks is made by the market, sipping their centrifuges”.

The data coming from Germany – adds the Commissioner, commenting on the news that the R with zero, the index of contagiousness of the virus, has returned to rise in Germany from 0.7 to 1.1 – shows how high the risk of go back to a total lockdown if the containment measures are relieved too quickly.

“The government is considering whether to define red areas again to avoid the extension of new outbreaks of infection, which start to appear again – he added – This is why getting out of the lockdown is not easy and that’s why being forced to return to the lockdown would not be difficult”

Returning to the question of masks, Arcuri reiterated that “the state must buy all the masks it finds. I set the maximum price in the interest of the citizens, I did not set the maximum purchase price. The state must encourage Italian production, as with ‘Cura Italia’: we reassured the producers that we will buy everything they produce. 105 thanked us, only one had any doubts. ” “The state must produce all the masks it can and encourage production, the idea that setting a maximum price reduces the Italian company’s ability to produce is superficial or very poorly informed – he adds -. Is it a war economy? No, It is civic sense. Is it forever? No, until the market is free. It is damage to the shameful speculators, I claim it. There will no longer be masks in pharmacies and supermarkets? Of course, none that cost more than 0 ,50 euros”.

“From Monday we could distribute 12 million masks per day, three times the current supply. From June we will reach 18 million, from July 25 million and when schools begin in September we could distribute 30 million masks per day, eleven times what we distributed at the beginning of the emergency. ” Extraordinary Commissioner Domenico Arcuri said this during a press conference on civil protection.

“The Premier Conte gave a multiplicity of information to the citizens as the moment required, he did not mention the contact tracing app, but it does not mean that the work does not proceed: tonight we have a coordination meeting. The app will use bluetooth technology and there is no contraindication. In May with the first functionalities, that is the contact tracing, it will be working, in the near future the functions closest to the clinical diary will also be active “, that is the connection with the National Health System. So did Commissioner Domenico Arcuri. It has not yet been decided whether the data collected by the App for contact tracing will be stored on citizens’ devices or on a public server added Arcuri stressing that obviously the choice will be made before ‘Immuni’ is activated.

“At the moment of development it will be possible to decide whether to leave them on the mobile phone and / or on a public and Italian server – he said – In any case nothing changes on the full and absolute guarantee of privacy” as the “data is encrypted”.

As for the issue of tampons, the Commissioner clarified that Italy “is the first country in the world for tampons made in relation to the number of inhabitants”. “There are still a few and more will have to be done, but let’s make peace with ourselves – he warned – and put citizens in the condition to have all the information and answers they deserve”.

According to the data, in Italy 2,960 swabs were made yesterday per one hundred thousand inhabitants, in 2,474 Germany, “20% less”, in Great Britain 1,061, one third of Italy, and in France 560, one sixth of our country.